Athernal Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $949K

  • Investors
  • 3

Athernal Bio General Information

Description

Developer of targeted immunotherapies designed for early intervention in blood cancer precursor conditions. The company's technology utilizes immunotherapy, targeted intervention, immune system training, mutation-specific target selection, immune-driven cell clearance, and precision delivery, enabling healthcare markets to eliminate mutation-bearing stem cells before they progress into established blood cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Babraham Labs
  • Cambridge
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
Corporate Office
  • Babraham Labs
  • Cambridge
  • England, United Kingdom

Athernal Bio Timeline

20252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Athernal Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 09-Sep-2026 $949K Completed Pre-Clinical Trials
2. Early Stage VC 13-Dec-2024 Completed Pre-Clinical Trials
1. Accelerator/Incubator $10K $10K Completed Pre-Clinical Trials
To view Athernal Bio’s complete valuation and funding history, request access »

Athernal Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
Delin Ventures Venture Capital Minority
Accelerate@Babraham Accelerator/Incubator
To view Athernal Bio’s complete investors history, request access »

Athernal Bio FAQs

  • When was Athernal Bio founded?

    Athernal Bio was founded in 2024.

  • Where is Athernal Bio headquartered?

    Athernal Bio is headquartered in Cambridge, United Kingdom.

  • What industry is Athernal Bio in?

    Athernal Bio’s primary industry is Drug Discovery.

  • Is Athernal Bio a private or public company?

    Athernal Bio is a Private company.

  • What is Athernal Bio’s current revenue?

    The current revenue for Athernal Bio is .

  • How much funding has Athernal Bio raised over time?

    Athernal Bio has raised $4.44M.

  • Who are Athernal Bio’s investors?

    Innovate UK, Delin Ventures, and Accelerate@Babraham have invested in Athernal Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process